Discover open access scientific publications

Search, annotate, share and cite publications

Publications by K. Nakagawa

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.04-29 Efficacy of Re-Treatment With Immune Checkpoint Inhibitors in Patients With Pretreated Advanced Non-Small Cell Lung Carcinoma

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.17-06 Salvage Surgery After Chemotherapy and/or Radiotherapy Including SBRT and Proton: Consecutive Analysis of 46 Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

MA15.03 PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial

Journal of Thoracic Oncology

Respiratory Medicine

English

OA02.07 Updated Results of Phase 1 Study of DS-8201a in HER2-Expressing or –Mutated Advanced Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-96 Clinical Characteristics of Non–Small Cell Lung Cancer Harboring Mutations in Exon 20 of EGFR or HER2

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.14-03 Phase II Trial of Amrubicin and Cisplatin Chemotherapy for Invasive Thymoma: WJOG5509L

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-34 Docetaxel Plus Ramucirumab With Prophylactic PEG-G-CSF Support for Chemo-NaïVe Elderly NSCLC Patients: A Phase II Study (WJOG9416L)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.15-004 Underrepresentation of Elderly Patients With ED-SCLC as Clinical Trial Candidates (JCOG1201/TORG1528)

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-75 RELAY+, an Exploratory Study of Gefitinib With Ramucirumab in Untreated Patients With EGFR Mutation-Positive Metastatic NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English